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Abstract
Background: In the most general sense, studies involving global analysis of gene expression aim
to provide a comprehensive catalog of the components involved in the production of recognizable
cellular phenotypes. These studies are often limited by the available technologies. One technology,
based on microarrays, categorizes gene expression in terms of the abundance of RNA transcripts,
and typically employs RNA prepared from whole cells, where cytoplasmic RNA predominates.
Results: Using microarrays comprising oligonucleotide probes that represent either protein-
coding transcripts or microRNAs (miRNA), we have studied global transcript accumulation
patterns for the HepG2 (human hepatoma) cell line. Through subdividing the total pool of RNA
transcripts into samples from nuclei, the cytoplasm, and whole cells, we determined the degree of
correlation of these patterns across these different subcellular locations. The transcript and
miRNA abundance patterns for the three RNA fractions were largely similar, but with some
exceptions: nuclear RNA samples were enriched with respect to the cytoplasm in transcripts
encoding proteins associated with specific nuclear functions, such as the cell cycle, mitosis, and
transcription. The cytoplasmic RNA fraction also was enriched, when compared to the nucleus, in
transcripts for proteins related to specific nuclear functions, including the cell cycle, DNA
replication, and DNA repair. Some transcripts related to the ubiquitin cycle, and transcripts for
various membrane proteins were sorted into either the nuclear or cytoplasmic fractions.
Conclusion: Enrichment or compartmentalization of cell cycle and ubiquitin cycle transcripts
within the nucleus may be related to the regulation of their expression, by preventing their
translation to proteins. In this way, these cellular functions may be tightly controlled by regulating
the release of mRNA from the nucleus and thereby the expression of key rate limiting steps in
these pathways. Many miRNA precursors were also enriched in the nuclear samples, with
significantly fewer being enriched in the cytoplasm. Studies of mRNA localization will help to clarify
the roles RNA processing and transport play in the regulation of cellular function.
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Background
Studies of global gene expression form an important com-
ponent of a systems approach to understanding cellular
function in normal and disease states. Although large-
scale gene expression data serve to define the state of cel-
lular systems [1], the perspective provided by any study of
this type is necessarily limited by the experimental meth-
ods employed for measuring gene expression. For exam-
ple, the transcriptome, defined as the entirety of all forms
of RNA transcribed from the genome, can be conceptually
and empirically subdivided into multiple parts, according
to subcellular location. The methods used for studying the
transcriptome can influence which subcellular compart-
ments are included in subsequent analyses, and further,
can determine what types of transcripts are included in the
studies.
RNA is transcribed first within the nucleus, wherein it is
accumulated to a steady state; this steady state is evidently
a complex function of the rates of synthesis, processing,
degradation, and export to the cytoplasm of the individ-
ual mRNAs [2,3]. Within the cytoplasm, the individual
mRNAs accumulate to different steady state levels, accord-
ing to their rates of export and to their different fates,
including translocation to specific subcellular locations
[4], translation on polyribosomes [3], sequestration
within localized organelles such as P bodies [5,6] for stor-
age and/or degradation mediated by microRNA (miRNA)
and short-interfering RNA (siRNA) [7]. Conceptually, the
levels of cytoplasmic RNAs, being located in the same
compartment as the translational machinery, might be
expected to correlate best with protein expression levels
for proteins encoded within the nuclear genome. The
transcript levels within the nuclear compartment, on the
other hand, since they comprise newly-transcribed RNA
albeit at much lower total amounts than the cytoplasm,
might be expected to track most proximally the actively-
transcribed portion of the chromatin, and therefore pro-
vide information concerning the most current transcrip-
tional program for the cell. Empirically, nevertheless,
global studies of gene expression, with few exceptions,
employ RNA samples that are whole-cell extracts, and
therefore are heavily weighted toward the contribution
provided by cytoplasmic RNA.
Recent studies have illustrated a number of pitfalls associ-
ated with using only one cellular RNA source for transcrip-
tome analysis. Cheng et al. [8] used Affymetrix tiling
arrays to study both nuclear and cytoplasmic transcripts.
They found that cytoplasmic RNA and nuclear RNA con-
tained different, yet overlapping, populations of tran-
scripts. Many of these transcripts represented portions of
the genome that were not previously recognized as being,
or predicted to be, transcribed, and included numerous
transcripts in antisense orientations. Further, many of the
transcripts in both pools were found to lack polyA
sequences, which would preemptively remove them from
any studies that use the polyA sequence to identify mRNA.
This study by Cheng et al. and similar ones [9-13], cou-
pled to the emerging importance of the regulatory activi-
ties of miRNA and siRNAs have considerably expanded
our view of the transcriptome and of how it might func-
tion within the cell. For example, in the Cheng studies,
31.8% of all RNA transcripts were from unannotated,
intergenic sequences, and 26% were intronic sequences.
They found that nuclear RNA is especially rich in non-cod-
ing sequences, with 41% consisting of intergenic
sequences and 25% intronic sequences. They also [8]
determined that 41.7% of cellular transcripts were found
only in the nucleus. Many of these transcripts were
intronic or intergenic, polyA- sequences; others included
small nucleolar RNAs, alternative splicing forms, and pri-
mary transcripts for miRNA (pri-miRNA). Pri-miRNAs
have been shown to reside almost entirely in the nucleus,
where they initially are processed by the RNAse Drosha
[14-16] prior to being exported into the cytoplasm in the
form of double-stranded RNA (pre-miRNA). In the cyto-
plasm, pre-miRNA is processed further by the Dicer
RNAse into small, single-stranded, mature miRNAs
[14,17].
As we revise our view of the transcriptome, comparisons
between nuclear and cytoplasmic RNA clearly serve to
expand our understanding of the expression and regula-
tion of even the best-annotated genes. Our pursuit of the
following experiments was generally motivated by the
practical goal of evaluating the validity of using isolated
nuclei as a source of transcripts for gene expression stud-
ies, but was also coupled to an interest in a more-detailed
understanding of the transcriptome. The interest in
nuclear RNA as a source of transcriptional information
stems from the empirical difficulties encountered in per-
forming global studies of gene expression in important
mammalian cell types that are interspersed within com-
plex tissues. Existing experimental strategies to isolate
interesting cells in this category, such as the beta cells
within the Islets of Langerhans, which comprise only 5%
of pancreatic cells, require dissociation from the matrix
tissue by digestion with proteolytic enzymes, and invoke
some method of cell separation and purification specific
to the beta cells. The time and conditions required for
processing the cells from tissue may severely compromise
their gene expression programs. We considered that these
problems might be mitigated if isolated nuclei, rather
than separated cells, were used for cell-type specific gene
expression studies, since nuclei can be isolated relatively
rapidly from tissue under conditions where new transcrip-
tion is halted. The basic approach is to tag nuclei in
unique cell types with a fluorescent marker by the intro-
duction of a Fluorescent Protein (FP) expressing trans-BMC Genomics 2007, 8:340 http://www.biomedcentral.com/1471-2164/8/340
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gene, driven by a cell type-specific promoter [18]. We and
others have established that the Green Fluorescent Protein
(GFP) can be efficiently targeted to the nucleus by fusion
to topogenic sequences [19-23]. Intact nuclei then can be
separated by homogenization at 4°C, and fluorescence
activated sorting (FAS) [24,25]. Previous studies in plants
have demonstrated the validity of this approach [22].
To explore the suitability of using nuclear RNA for global
gene expression studies, we have compared global gene
expression patterns derived from transcripts produced
from nuclear and cytoplasmic extracts of the HepG2
human hepatoma cell line. Further, we have compared
global gene expression patterns between transcripts from
nuclear and total cellular extracts. We used human
genomic microarrays for these studies, which provide a
broad survey of the annotated portions of the transcrip-
tome. Since many of the uniquely nuclear forms of RNA
are not well represented on microarrays designed for gene
expression, we also employed microarrays designed for
analysis of miRNA expression [26]. We used them in a
manner different from their designed purpose, by
employing methods for transcript purification and ampli-
fication that exclude mature miRNAs, but that include the
larger primary transcripts for miRNAs containing intact
polyA sequences.
Our results indicate that global gene expression patterns
based on microarray analyses are largely congruent for
total, cytoplasmic, and nuclear RNA samples extracted
from HepG2 cells. However, there were some significant
differences between nuclear and cytoplasmic RNA; for this
comparison, the reported transcript concentrations dif-
fered significantly between the compartments for 3% of
the transcripts represented on the microarrays. Analysis of
the annotation of transcripts that were significantly differ-
ent between the nuclear and cytoplasmic fractions sug-
gests they may play important roles in the control of key
processes within the cell. A further finding from these
experiments, that pri-miRNA transcripts were largely con-
centrated in the nucleus, is consistent with previous find-
ings that pri-miRNA transcripts are processed in the
nucleus prior to transport into the cytoplasm.
Results
The HepG2 human hepatoma cell line was selected as a
model system for transcript profiling within nuclear, cyto-
plasmic, and total RNA fractions. RNA fractions were pre-
pared from four different passages of cells that were
approximately 80% confluent, to provide some biological
variability. Following amplification, labeled RNAs were
hybridized to human genomic microarrays comprising
70-mer sense-strand array elements. The same RNA sam-
ples were also processed for hybridization using miRNA-
specific microarrays.
Correlation plots of log median intensity values for
nuclear, cytoplasmic, and total RNA were compared for
both the human genomic and miRNA arrays (Figures 1
and 2). The high correlation coefficients imply a high
degree of technical reproducibility of the overall microar-
ray platform, including the amplification step, and a lack
of biological variation across different samples. The great-
est differences in transcript and miRNA levels were
observed within comparisons of nuclear and cytoplasmic
fractions. Given that a majority of the total cell RNA frac-
tion comprises cytoplasmic RNA, this is not surprising.
Overall, smaller magnitude differences were seen within
the comparisons using the miRNA microarrays as com-
pared to the genomic expression microarrays.
Comparison of mRNA Isolated from Cytoplasmic and 
Nuclear Compartments
For the transcripts represented on the human genomic
arrays, we tabulated those that displayed consistent differ-
Human genomic microarrays: a comparison of intensity val- ues for nuclear, cytoplasmic, and total RNA samples Figure 1
Human genomic microarrays: a comparison of inten-
sity values for nuclear, cytoplasmic, and total RNA 
samples. The median intensity values from the hybridization 
of amplified RNA samples to the 70-mer probes on the 
human genomic microarrays were log-transformed and nor-
malized. The least-squares mean log values from the mixed 
model ANOVA were plotted against each other to view the 
relative intensities for the following samples: Blue, nuclear 
(ordinate) versus cytoplasmic (abscissa) RNA; Green, nuclear 
(ordinate) versus total (abscissa) RNA; and Red, total (ordi-
nate) versus cytoplasmic (abscissa) RNA. A least squares 
regression line was fitted to each set of points to visually 
demonstrate the linear relationship; the associated correla-
tion coefficients are presented in colors that match the lines 
and the data points.BMC Genomics 2007, 8:340 http://www.biomedcentral.com/1471-2164/8/340
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ential expression between the nuclear and cytoplasmic
fractions, as determined by analysis of variance (ANOVA).
The criterion for significance was defined as a false discov-
ery rate (FDR) less than or equal to 0.05 [see Methods and
Additional file 1]. The transcripts meeting this criterion, a
total of 743 (3.5%) out of the 21,383 represented on the
array, were divided into two classes, those expressed at
higher levels in the nucleus (389 transcripts), and those
expressed at higher levels in the cytoplasm (354 tran-
scripts). The magnitude of the enrichment of transcripts in
the nuclear RNA fraction relative to the cytoplasm ranged
from 1.14 fold to more than 12 fold, with 321 transcripts
being more than 1.5-fold higher, and 192 more than 2-
fold. For transcripts enriched in the cytoplasm relative to
the nucleus, the range was from 1.16 to 5-fold, with 301
transcripts being more than 1.5-fold higher than in the
nucleus, and 171 more than 2-fold.
After annotation of the transcripts that were enriched in
the nucleus, the gene ontology distributions were ana-
lyzed using the GOToolBox [27]. We searched for annota-
tion classes that were overrepresented when compared to
the human genome, as determined with a hypergeometric
test, using the Benjamini and Hochberg correction to
compensate for multiple testing [28,29]. Several annota-
tion classes were overrepresented, including the GO cell
component term nucleus (Figure 3). Many of the biologi-
cal processes that were overrepresented were associated
with the nucleus (Figure 4), including the cell cycle, mito-
sis, and transcription. Other classes overrepresented for
transcripts enriched in the nucleus were for membrane-
associated proteins, particularly those integral to the
plasma membrane and the Golgi apparatus. Glycosyl-
transferases, which are generally membrane-associated
proteins, also were overrepresented in the nuclear-
enriched transcript fraction. Some GO headings related to
the nucleus were represented but not significantly over-
represented among the nuclear-enriched transcripts,
including those encoding chromatin assembly factors,
and RNA processing enzymes. Finally, the class of tran-
scripts associated with the ubiquitin cycle, discussed in
more detail below, was also overrepresented in the list of
nuclear-enriched transcripts.
When the transcripts that were enriched in the cytoplasm
in comparison to the nucleus were analyzed, many of the
same annotation classes found for nuclear-enriched tran-
scripts were determined to be overrepresented in compar-
ison to the whole genome, including the cell component
'nucleus' heading. Some of the overrepresented GO bio-
logical process classes for the cytoplasm-enriched tran-
scripts included cell cycle, mitosis, metabolism, DNA
repair, DNA replication, chromatin assembly/disassem-
bly, and RNA processing. The cytoplasm-enriched tran-
scripts also had overrepresentation in the cell component
classes of membrane-associated genes, including endo-
plasmic reticulum, plasma membrane, and Golgi appara-
tus, as well as the classes mitochondrion, proteasomes,
and response to stress. Other classes that were conspicu-
ously represented but not enriched included the ubiquitin
cycle, and transcription.
Micro (mi)RNA Analysis
The same amplified RNA samples used with the human
genomic microarrays were reverse-transcribed and
labeled, so that they could be used with the MirMax
miRNA microarrays, which consist of antisense, single
stranded oligonucleotides representing 759 different miR-
NAs [26]. In these experiments, the RNA forms that were
amplified [30] necessarily have a polyA tail, and are large
enough to be purified by the Qiagen RNeasy procedure,
which enriches for RNA greater than 200 nt in length.
Mature miRNA and pre-miRNA, typically 22 nt and 70 nt
in length respectively, are not purified or amplified effi-
ciently under these conditions, but amplification of
MicroRNA microarrays: a comparison of intensity values for  nuclear, cytoplasmic, and total RNA samples Figure 2
MicroRNA microarrays: a comparison of intensity 
values for nuclear, cytoplasmic, and total RNA sam-
ples. Sense DNA (reverse-transcribed, amplified RNA) sam-
ples were hybridized to the oligo probes (doublets of 18–22 
nucleotides) on the MirMax miRNA microarrays. Hybridiza-
tion of these samples to the miRNA arrays indicates the con-
centration of pri-miRNA in the RNA samples. The resulting 
intensity values were analyzed as given in Figure 1, and plot-
ted with the same color key. A least squares regression line 
was fitted to each set of points to visually demonstrate the 
linear relationship; the associated correlation coefficients are 
presented in colors that match the lines and the data points.BMC Genomics 2007, 8:340 http://www.biomedcentral.com/1471-2164/8/340
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miRNA primary transcripts does occur, as they are polya-
denylated, and are typically several hundred to several
thousand nucleotides in length [16,31,32].
The fluorescence intensity data from scanning the MirMax
arrays indicate that pri-miRNA is detected in these sam-
ples. Many of the human pri-miRNAs detected are for
miRNAs that have been previously identified in liver cells,
such as let-7b, miR-16, miR-92, miR-93, miR-122a, miR-
125a, miR-125b, miR-150, miR-151, and miR-345 [33-
35]. Human miR-122 has not been found in HepG2 cells
previously, but our experiments do indicate that the pri-
mary transcript for miR-122 is present in our cultures
[35].
Analysis of the miRNA hybridization data by ANOVA
indicated differential miRNA accumulation between the
nuclear and cytoplasmic RNA samples, at a FDR of less
than 0.05, for 156 of the miRNA precursors. The Mirmax
arrays are divided into subarrays that comprise probe sets
for five species: human, mouse, rat, D. melanogaster, and
C. elegans. Of the probes that showed significant differ-
GO cell component analysis of nucleus-enriched and cytoplasm-enriched transcripts Figure 3
GO cell component analysis of nucleus-enriched and cytoplasm-enriched transcripts. The lists of nucleus-enriched 
(relative to cytoplasm) and cytoplasm-enriched (relative to nucleus) transcripts were calculated for the human genomic micro-
array data by ANOVA and by selection of those with a FDR less than 0.05. These two lists were submitted independently for 
analysis by GOToolbox [27] to determine the cell component annotation of the transcripts, and to determine whether some 
of the annotation categories were overrepresented on the lists, using the hypergeometric test with Benjamini and Hochberg 
FDR calculation. Some of the categories with strong representation among the transcripts are presented here. The transcripts 
that were placed in each category are identified by gene name or abbreviated TREMBL identifier and color-coded to indicate 
the ratio of the log, mean, normalized intensity values of the nuclear sample over the cytoplasmic sample. Where the lists for 
nuclear or cytoplasmic transcripts show overrepresentation in a GO category, the FDR is provided.
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ences, 116 were for non-human miRNAs. Of these, 36
were exact duplicates of probes for known human miR-
NAs, reflecting the high degree of cross-species conserva-
tion of some miRNAs [36,37]. In these cases, the probes
for other species were technical replicates for the human
miRNA probes, and the corresponding data reflected this.
For example, hsa-miR-let7e had the highest nuclear to
cytoplasmic ratio for human miRNAs, at 2.84, and the
mouse and rat duplicates had ratios of 2.67 and 1.88,
respectively.
Some of the probes for other species may identify novel
human miRNAs; for example, the mouse probe for miR-
207 is in the group showing significant differences, but no
human homologue for this microRNA has been identi-
fied. The sequence for mouse miR-207 is found in the
human genome. In other cases, such as for mouse miR-
151 or Drosophila miR-34, the probes are different from
those used for the human homologues, but these miRNAs
have human counterparts [38,39]. For miR-151, the data
for the human probes were very similar to the correspond-
ing data for the mouse probes, but did not show signifi-
cant differences in amounts between the nuclear and
cytoplasmic RNA samples. For human miR-34, the data
did show significant differences. For miR-34 and miR-
151, the probes for the non-human microRNAs may be
hybridizing to the human pri-miRNAs, but because the
probe sequences are not designed specifically for the
GO biological process analysis of nucleus-enriched and cytoplasm-enriched transcripts Figure 4
GO biological process analysis of nucleus-enriched and cytoplasm-enriched transcripts. Details are the same as for 
Figure 3, except the lists of transcripts were annotated using the biological process categories.
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human homologues, the hybridized targets could be dif-
ferent microRNAs or other RNA sequences. Our samples
hybridized strongly with the probes for both mouse and
rat probes for miR-290, miR-292-5p, miR-297, miR-298,
and miR-329. Only mouse miR-329 and rat miR-329 have
a known human homologue, but there were no probes for
the human miR-329 on this array. The human miR-329
was discovered in a search for sequences homologous to
the rat miR-329 [40], but in our experiments, because the
sequence is not identical to the sequence for the mouse or
rat homologues, the rat and mouse probes may not have
hybridized to a miR-329 primary transcript. Thus, each of
the miRNA precursors hybridized by mouse or rat miRNA
probes could potentially represent human homologues,
but each must be examined on an individual basis to
determine whether such homologues exist.
The list of 156 miRNA probes that showed a significant
difference between the nuclear and cytoplasmic fractions
was reduced to 121 to eliminate some redundancies. For
the 121 probes, the log-ratio data comparing the mean,
normalized intensities for nuclear to cytoplasmic, nuclear
to total, and cytoplasmic to total RNA fractions were sub-
jected to cluster analysis (Fig. 5). Most of the pri-miRNAs
formed two groups that both contained pri-miRNAs more
concentrated in the nucleus. A much smaller group of pri-
miRNAs hybridized less intensely with the nuclear sam-
ples when compared to the cytoplasm and/or the total
RNA fractions, indicating a higher pri-miRNA concentra-
tion for these in the cytoplasm. One of the pri-miRNA
groups that was higher in the nucleus had only 4 mem-
bers, but they showed particularly high nuclear to cyto-
plasm ratios for their intensities. The only human miRNA
pri-miRNA in this group was for let-7e, but the group also
contained the probe for mouse miR-329. The other two
members, were hybridized to the probes for mouse miR-
106a and mouse miR-325. The corresponding human pri-
miRNAs fell into the larger group with high nuclear to
cytoplasmic ratios.
Discussion
The primary purpose of these experiments was to explore
the suitability of using nuclear RNA, as compared to total
RNA, or its predominant component, cytoplasmic RNA,
for studying global gene expression. Our interest in
nuclear RNA was based on two practical considerations:
first that nuclei could be directly purified at 4°C from cel-
lular homogenates using fluorescence-activated sorting
[24,25]; and second, that nuclei could be labeled through
transgenic expression and targeting of Fluorescent Pro-
teins within specific cell types [21,22]. Thus, combining
high RNA integrity with the ability to isolate genetic mate-
rial in a cell-type specific manner provided a unique
approach for studying gene expression in select cell types.
Our previous studies [22,25], which employed higher
plants, served as the model for extending this approach to
mammalian cells, with the aim of validating it and estab-
lishing its generality for multicellular eukaryotes. Evi-
dently, global analyses of cytoplasmic RNA transcripts
appear more likely to reflect the patterns of protein bio-
synthesis at any particular time, whereas analyses of
nuclear transcripts appear more likely to track the process
of transcription. It therefore was of interest to explore the
global similarities and differences between the transcript
populations in these two cellular locations, and for this
purpose microarrays were employed. Two microarray
platforms were available; in the first case, the oligonucle-
otide array elements represented annotated gene tran-
scripts. In the second case, the array elements represented
microRNAs. To simplify the biological system, we
employed human HepG2 cells growing in culture, which
represent a relatively homogeneous population of cells.
Evaluation using a Bioanalyzer (Agilent, Santa Clara, CA)
indicated that we were able to prepare RNA of excellent
quality from the sorted HepG2 nuclei, and this RNA was
sufficient in quantity for microarray target preparation
using one round of amplification. Microarray hybridiza-
tion was highly reproducible, yielding a list of 744 tran-
scripts for the human genome platform and 156
transcripts for the miRNA platform, that were expressed at
significantly different intensities in the nuclear and cyto-
plasmic RNA fractions, based on a criterion of a false dis-
covery rate of less than 0.05.
Considering first the analysis of annotated, protein-cod-
ing gene transcripts, we were able to demonstrate that
nuclear RNA hybridization patterns were very similar to
those obtained using either total or cytoplasmic RNA.
When transcripts of the nuclear and the cytoplasmic com-
partments were compared, only 3% of all transcripts were
found at significantly different levels. Approximately-
equal numbers of gene transcripts were enriched within
and depleted from the nucleus (389 versus 354 tran-
scripts, respectively). This observation demonstrates that
an analysis of nuclear transcripts can be used as an accu-
rate gauge of the general global pattern of transcript regu-
lation for a cell, and it validates an important step of the
proposed strategy of employing flow sorting for enrich-
ment of the nuclei of specific cell types, followed by
nuclear transcript profiling [41].
The observation that a small minority of the transcripts
were significantly enriched in the nucleus or cytoplasm
raises the question as to the biological purpose of this
enrichment, and the related question as to how it might
be achieved. The demonstration of differential expression
within two cell fractions is evidence for the relative purity
of the nuclear fractions, and evidence that the segregation
of transcripts is an important function for the cell. The
enrichment of some transcripts in the nucleus with respectBMC Genomics 2007, 8:340 http://www.biomedcentral.com/1471-2164/8/340
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to the cytoplasm may suggest that the rate of transcription
for these genes is relatively high, and conversely, their rate
of release to the cytosol low and/or their rate of degrada-
tion in the cytosol is high [42]. Enrichment of transcripts
in the cytoplasm with respect to the nucleus could also
imply that the stability of the transcripts is relatively high,
and that their transcription rates are low.
Other explanations for the selective enrichment of tran-
scripts within one subcellular compartment could include
the physical association of the RNA with specific cellular
structures. For example, some mRNAs, including those
coding membrane proteins and glycoproteins, are associ-
ated by polyribosomal translation with the endoplasmic
reticulum (ER) membranes. Transcripts for proteins des-
tined for various other endomembrane locations are also
expected to be associated with the ER. Since the ER has
functional continuity with the outer nuclear membrane,
this could explain the enrichment of membrane protein
transcripts with the nuclei [43-45]. In that some of the
Cluster analysis of the miRNA primary transcripts identified in the nuclear, total, and cytoplasmic fractions of the HepG2 cells Figure 5
Cluster analysis of the miRNA primary transcripts identified in the nuclear, total, and cytoplasmic fractions of the HepG2 cells. 
Analysis is based solely on the log ratios of the mean normalized intensity values from the hybridization of the reverse-tran-
scribed amplified RNA samples to the miRNA microarrays. The Cluster and Treeview programs that are found on the GEPAS 
website [69] were used to compare 1)nuclear to cytoplasmic, 2)nuclear to total, and 3)cytoplasmic to total ratios, which are 
color-coded to represent the log ratios of the mean intensity values as indicated. The clustering was performed with complete 
linkage using the euclidean distance, and the unweighted pair group method with arithmetic averages.BMC Genomics 2007, 8:340 http://www.biomedcentral.com/1471-2164/8/340
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proteins produced in the ER are specifically targeted to the
nucleus, this would explain the enrichment in the nuclear
fractions of some of the transcripts for nuclear proteins
[44,46,47].
Clues to the purpose of the spatial segregation of tran-
scripts within the cell may be found in the annotational
analysis of the nucleus-enriched and cytoplasm-enriched
transcripts. For example, the ontology categories that were
overrepresented in the list of transcripts enriched in the
nucleus included the cell cycle and the ubiquitin cycle.
Both categories relate to rapid changes in the program-
ming of the cell. Additionally, transitions of state associ-
ated with operation of the cell cycle require rapid changes
in both the transcriptome and in the proteome, the latter
being regulated by ubiquitination and protein degrada-
tion within proteasomes. Thus, the purpose of the spatial
segregation of transcripts may be to regulate the activity of
a functional pathway, by controlling which transcripts are
expressed constitutively in the cytoplasm, and which ones
are held in the nucleus away from the translational
machinery.
The potential importance of regulation by separation of
transcripts is illustrated in Fig. 6, which was created with
the program Osprey, a protein-interaction visualization
tool [48]. Osprey was used to consider possible interactive
relationships between the proteins coded by the genes
that are enriched in either the nucleus or the cytoplasm.
The interactions identified by Osprey are documented
from experiments in vitro and in vivo, by yeast two-hybrid
studies, and by affinity-capture mass spectrometry, all
integrated into a single database, The Biogrid [49]. The
network created using Osprey (Figure 6) represents a
small fraction of the 389 nucleus-enriched and 354 cyto-
plasm-enriched genes, but helps illustrate how the separa-
tion could be important to some regulatory pathways. The
network linked together some of the protein products of
nucleus-enriched transcripts through a central ubiquitin-
conjugating enzyme, UBE2I  (Table 1). Including cyto-
plasm-enriched transcripts in the analysis enlarged the
network to include both nuclear-enriched and cytoplasm-
enriched transcripts. The nuclear enriched transcripts rep-
resented in this linked pathway were related to apoptosis
(PTEN1,  MITF,  TRADD, AHR, TERT), the cell cycle
(PTEN1, HIPK2, AHR), and the stress response (AHR).
The cytoplasm-enriched transcripts included three small
ubiquitin modifiers (SUMO1, SUMO2, and SUMO3), as
well as other proteins related to DNA repair (APEX1,
XRCC1, and G22P1), the cell cycle (the small ubiquitin
modifiers [50], and cyclin T1), and the stress response
(AHSA1, and the 90 kDa heat shock protein, HSP90AA1).
The network defined by Osprey suggests that transcripts
that are expressly segregated within the cell, the cyto-
plasm-enriched transcripts and the cytoplasm-depleted
transcripts, encode proteins that may interact in regulat-
ing the closely-interrelated functions of the cell cycle,
DNA repair, the ubiquitin cycle, apoptosis, and the stress
response. At least one transcript that was retained in the
nucleus (UBE2I) occupied a central position in this net-
work linking together several other components.
A novel mechanism for the nuclear retention of transcripts
has been previously proposed [51-53]. Prasanth et al.
demonstrated that the transcript for SLC7A2, a mouse cat-
ionic amino acid transporter, was normally localized to
the nucleus. After stress induction by treatment with α-
amanitin, a large portion of the SLC7A2 transcripts were
redistributed into the cytoplasm. Further, they showed
that retention was related to adenosine to inosine edits
found in the 3'UTR of the nuclear transcripts, and that
cleavage of this edited portion was required for the trans-
location into the cytoplasm. The adenosine to inosine
edits were the result of the activity of a well-documented
enzyme, adenosine deaminase, which acts on double-
The lists of nucleus-enriched and cytoplasm-enriched tran- scripts were analyzed for potential interactions by the pro- teins represented by the transcripts Figure 6
The lists of nucleus-enriched and cytoplasm-enriched tran-
scripts were analyzed for potential interactions by the pro-
teins represented by the transcripts. The analysis was 
performed with Osprey software, which employs The Biog-
rid [49], a database of protein-protein interactions based on 
in vitro, in vivo, yeast two-hybrid system, and affinity-capture 
mass spectrometry experimentation. The main grouping of 
interacting proteins that resulted is presented here. Those 
proteins that represented nucleus-enriched transcripts are 
marked with an 'N'. The proteins are labeled with the corre-
sponding gene name, and the annotation information for the 
proteins is provided in Table 1. Each protein is color coded 
according to its annotation heading. The experimental sys-
tem(s) employed to determine the protein-protein relation-
ship is indicated by the color coding of the arrows.
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stranded RNA, and was previously shown to cause the
retention of viral RNA in the nucleus [53,54].
The proposed model for nuclear retention [51] could
explain the enrichment of transcripts in the nuclear frac-
tion with respect to the cytoplasm observed in our studies.
Prasanth et al. [51] have proposed that the nuclear reten-
tion of the SLC7A2  transcript is a component of the
response of the cell to stress, and that more generally,
nuclear retention of transcripts could be an important
stress response mechanism. In our experiments, we did
not see a statistically significant overrepresentation of
transcripts for the stress response in the nuclear-enriched
transcripts, with an exception for the subcategory of stress-
activated protein kinase signaling. Nonetheless, we found
specific stress-related genes among our nuclear-enriched
transcripts, including one for another cationic amino acid
transporter important to the stress response, SLC7A11
[55]. We also found a significant presence of ubiquitin
cycle components among the nuclear-enriched tran-
scripts, the ubiquitin cycle being also important to the
stress response [56,57]. Our data suggest a possible
broader role for nuclear retention that includes other
processes that require a rapid change in the cell program.
Conclusive information as to whether the nuclear reten-
tion model is in play will require complete analysis of the
sequences of 3'UTRs of the transcripts enriched with
respect to the cytoplasm. Adenosine to inosine edits can
be detected by comparing multiple transcript sequences
for the same gene, since the edited adenosines are repre-
sented as guanosines in cDNA sequences. In a search of all
human transcripts available in Genbank, Levanon et al.
[58] found 1,637 genes with variant transcripts that had
adenosine to inosine edit sites. 92% of the edit sites were
associated with ALU repeats, which were also associated
with the hairpin structures described in the 3'UTR of
SLC7A2 transcripts [51]. We compared our list of 389
nuclear-enriched transcripts to the list of transcripts iden-
tified by [59]. Of the 292 transcripts of our list having
annotated gene names, which allowed cross-referencing
between the two lists, 22 (7.5%) also appeared in the list
of transcripts containing adenosine to inosine editing
sites [59]. This supports the idea that some of the nuclear-
Table 1: Proteins in the Interaction Network
Name Description Go Component Go Process
AHR aryl hydrocarbon receptor nucleus cell cycle;response to stress;apoptosis
AHSA1 AHA1, activator of heat shock 90 kDa ATPase 
homolog 1 (yeast)
ER;cytoplasm response to stress;protein folding
APEX1 APEX nuclease (multifunctional DNA repair 
enzyme) 1
nucleus;ER;ribosom base-excision repair;DNA repair
CCNT1 cyclin T1 nucleus cytokinesis;regulation of cell cycle
G22P1 X-ray repair in Chinese hamster cells 6 nucleus double-strand break;DNA repair
HIPK2 homeodomain interacting protein kinase 2 nucleus;nuclear body;cytoplasm apoptosis;reg. of cell cycle
HSP90A1 heat shock 90 kDa protein 1, alpha cytosol mitochondrial transport;protein refolding
MITF microphthalmia-associated transcription factor nucleus regulation of transcription; melanocyte 
differentiation
NUDCD3 NudC domain containing 3 NONE NONE
PIAS1 protein inhibitor of activated STAT, 1 nucleus ubiquitin cycle;regulation of transcription
PTEN1 phosphatase and tensin homolog (mutated in 
cancers 1)
cytoplasm negative reg. of cell cycle;induction of apoptosis
SET SET translocation (myeloid leukemia-
associated)
ER;perinuclear region;nucleus nucleocytoplasm transport;DNA 
replic.;nucleosome assembly
SUMO1 SMT3 suppressor of mif two 3 homolog 1 
(yeast)
nucleus ubiquitin cycle;protein modification;protein 
sumoylation
SUMO2 SMT3 suppressor of mif two 3 homolog 2 
(yeast)
nucleus ubiquitin cycle;protein modification
SUMO3 SMT3 suppressor of mif two 3 homolog 3 
(yeast)
kinetochore ubiquitin cycle;protein modification
TERT telomerase reverse transcriptase chromosome, telomeric 
region;nucleus
RNA-dependent DNA replication;telomere 
maintenance
TRADD TNFRSF1A-associated via death domain NONE induction of apoptosis
TXN thioredoxin NONE electron transport;cell-cell signaling;cell 
motility;cell prolif.
UBE2I ubiquitin-conjugating enzyme E2I (UBC9 
homolog, yeast)
NONE ubiquitin cycle;protein modification
XRCC1 X-ray repair in Chinese hamster cells 1 intracellular;nucleus single strand break repairBMC Genomics 2007, 8:340 http://www.biomedcentral.com/1471-2164/8/340
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enriched transcripts can be variants that are retained in the
nucleus. The other transcripts on our list of nuclear-
enriched transcripts also may have adenosine to inosine
editing sites, but these sites remain to be identified.
The nuclear retention model would best explain much of
the spatial segregation of transcripts implied by our data.
Localization of mRNA may relate most directly to the reg-
ulation of some processes within the cell. Nuclear reten-
tion may hold transcripts aside, untranslated, until they
are needed by the cell. Rapid release of the transcripts to
the cytoplasm would allow fast expression of key proteins,
for example, UBE2I in the protein interaction network
described above. Without this key protein, important
ubiquitin-mediated pathways may be inactive, until the
transcript for UBE2I is released from the nucleus.
In terms of transcripts not destined for translation, such as
ribosomal RNA (rRNA) and miRNA, we would expect that
nuclear RNA would be enriched for primary or precursor
forms of these transcripts. The primary transcript of rRNA
contains both 18S and 28S rRNA sequences. Processing of
the transcript takes place in the nucleoli, where the indi-
vidual rRNA components are assembled into the ribos-
omes [60]. miRNA is processed in a more complex
fashion, being produced first as a large, polyadenylated
primary transcript (pri-miRNA), which is processed
within the nucleus by the Drosha ribonuclease into an
intermediate precursor form (pre-miRNA), which is trans-
ported to the cytoplasm and then cleaved by the Dicer
RNAse to the final, active miRNA [14,32]. Very little of the
full-length transcript ever reaches the cytoplasm [15,16].
Our data obtained using miRNA-specific arrays confirmed
that the levels of pri-mRNAs were elevated within nuclear
extracts when compared to the cytoplasm [15,16]. The
RNA purification and amplification protocols that we
employed limited our studies to the polyadenylated pri-
miRNA, and excluded consideration of mature miRNA.
Our data (Figure 5) indicated that the majority (72%) of
the pri-miRNA transcripts were enriched in the nucleus.
A relatively small number of pri-miRNAs were slightly
enriched in the cytoplasm with respect to the nucleus.
One would not expect pri-miRNAs ever to be higher in the
cytoplasmic or total fractions. Either this small group of
transcripts consists of exceptions to the general rule, or a
number of artifacts may have created this result. One such
artifact could result from leakage from damaged nuclei,
which could be compounded by the much longer prepa-
ration time for the nuclear samples (approximately 1–1.5
hr vs. less than 15 min for cytoplasmic samples, which
were prepared from a separate flask). The longer prepara-
tion time for the nuclear samples, though maintained at
4°C, may also allow Drosha to selectively reduce the
nuclear signal. Contamination of the cytoplasmic RNA
with nuclear RNA is not likely to be an important factor in
itself. Nuclear RNA typically makes up approximately 10–
15% of the total RNA, and so even if half of the nuclear
RNA contaminated the cytoplasmic RNA, the maximal
contamination would be 8%, a proportion too small to
permit the cytoplasm to be more enriched in a putatively
contaminating transcript than the nucleus itself. A more
trivial artifact may result from cross-hybridization with
mRNA, which certainly could be the case for the probes
for non-human miRNAs that make up a disproportionate
fraction (67%) of this group. It is also possible that some
miRNAs are not completely processed in the nucleus
before passage to the cytoplasm. Some miRNAs are tran-
scribed within the introns of protein coding transcripts,
and some are found within the exons or introns of non-
translated mRNA-like transcripts. These transcripts could
possibly be processed outside of the nucleus [61].
Conclusion
The nucleus serves a central role in the programming of a
cell, and so it is not unusual that multiple processes are
reflected in the enrichment of transcripts either within the
nuclear compartment or away from the nucleus in the
cytoplasm. Clearly the current cell program is well repre-
sented by the new transcripts produced in the nucleus,
and these new transcripts may first appear as precursors or
partially processed transcripts, as in the case of pri-
miRNA. Some transcripts in the nucleus may be untrans-
lated variants that are retained until they may be rapidly
processed and transported to the cytoplasm when needed
by the cell. Other transcripts may be associated with our
nuclear fractions because they are enriched in a part of the
ER or other membrane structure connected to the nucleus.
Some transcripts may be routed directly to the cytosol for
immediate translation. The localization of transcripts
within the cell provides clues to the regulation of the RNA
species or the proteins that they may code. Much more
study is needed before we have a more comprehensive
view of how the movement and segregation of transcripts
function in cellular programming. Specifically we plan to
sequence the transcripts segregated within the cell to
determine if they have adenosine to inosine modifica-
tions. We will also examine further the localization of pri-
miRNAs within the cell, to determine whether some of
them have unprocessed or partially processed forms that
reach the cytoplasm.
Methods
Cell culture
HepG2 human hepatoma cells (American Type Culture
Collection, Manassas, VA) were grown in Dulbecco's
Modification of Eagle's Medium without L-glutamine,
supplemented with 4.5 gm/L glucose, 110 mM sodium
pyruvate, 15 mM HEPES, 10% fetal calf serum, penicillin,BMC Genomics 2007, 8:340 http://www.biomedcentral.com/1471-2164/8/340
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streptomycin, and Glutamax-I (1X, Invitrogen, Carlsbad,
CA). Cells were cultured to approximately 80% conflu-
ence in 75 cm2 flasks prior to harvest. Four biological rep-
licate samples were prepared on different days. Each
biological replicate employed 5 flasks plated with cells at
the same time. For each day, separate flasks were proc-
essed simultaneously to produce nuclear, cytoplasmic,
and total RNA samples.
Preparation of nuclear RNA
Three 75 cm2 flasks of HepG2 cells were placed on ice and
incubated for 5 min with 10 ml of ice-cold HMS buffer
(8% Sucrose, 25 mM KCl, 5 mM MgCl2, 20 mM Tris-HCl,
pH 7.4). The buffer was withdrawn and replaced with 2
ml HMS, and the cells were scraped from the flask surface
with a plastic cell scraper. The cells were immediately
homogenized on ice in a Dounce homogenizer, with 10
strokes of a loose-fitting pestle, followed by 30 strokes
with a tight-fitting pestle. The homogenate was filtered
through a 40 µm nylon mesh screen, and the volume
adjusted to 3 ml with HMS. DAPI (4',6-diamidino-2-phe-
nylindole) was added to a final concentration of 0.67 µg/
ml and incubated for 10 min at 4°C. The homogenate was
layered on top of a 2-step gradient consisting of 5 ml lay-
ers of 12.5% and 35% iodixanol. The layers were prepared
by mixing the 60% stock solution of iodixanol (Sigma,
St.Louis, MO) 5:1 with 0.12 M Tris-HCl, pH 7.4, 0.15 M
KCl, 30 mM MgCl2 to make buffer HMI. Buffers HMI and
HMS were mixed in appropriate proportions to constitute
the gradient layers. The homogenate and gradient were
centrifuged for 25 min at 4500 × g at 4°C, and the lower
interface, containing the nuclei, was removed. This sam-
ple was very gently diluted to 4 ml with HMS. The nuclei
were further purified using a MoFlo flow cytometer/cell
sorter (Dako North America, Inc., Carpinteria, CA),
equipped with a Coherent Enterprise II laser providing 50
mW at 365 nm and 200 mW at 488 nm. The filter config-
uration routed DAPI fluorescence to a 450/65 bandpass
filter with 90° light scatter (side scatter) being detected
using a 95/5 dichroic and a 480/10 barrier filter. Samples
were sorted at a rate of 500–1000 nuclei/s. Data were vis-
ualized as biparametric histograms of log DAPI vs. log
side scatter which were triggered on side scatter. A sort
window was selected to minimize contaminants, espe-
cially from smaller cell particles. We examined prepara-
tions of nuclei by light and epifluorescence microscopy,
and found that they contained largely nuclei and a small
amount of free membranes. The sorted nuclei were col-
lected directly into RLT buffer (Qiagen, Valencia CA), at a
ratio of 0.4 nuclei to 2 ml RLT. Nuclear samples were
either frozen at -80°C or RNA was extracted immediately,
according to the Qiagen RNeasy Minikit protocol. A
DNase treatment step was included in the preparation
protocol according to the Qiagen instructions. Cells and
nuclei were maintained at 4°C to reduce the possibility of
transcription in the nuclei or degradation of the RNA.
Additionally, the DAPI used to stain the nuclei was well
above the IC50 for inhibition of initiation of transcription
by RNA polymerase II [62].
Preparation of cytoplasmic RNA
Cytoplasmic RNA was prepared according to the Qiagen
(Valencia, CA) RNeasy Minikit protocol. A 75 cm2 flask of
HepG2 cells (separate from those used for the nuclear
preparation) was placed on ice, the growth medium was
removed and 1.75 ml of RLN buffer (50 mM Tris-HCL pH
7.4, 0.14 M NaCl, 1.5 mM MgCl2, 0.5% IGEPAL 630
detergent, with 40 U/ul RNasin (Promega Biosciences,
Inc., Madison, WI) was added. After incubating on ice for
5 min, the cells were scraped from the flask, and the result-
ing homogenate was centrifuged for 3 min at 300 × g at
4°C. The supernatant was combined with 6 ml Qiagen
RLT (lysis) buffer and RNA was prepared according to the
Qiagen instructions or frozen at -80°C. A DNase treat-
ment step was included in the preparation protocol
according to the Qiagen instructions.
Preparation of total RNA
The growth medium was removed from a 75 cm2 flask of
HepG2 cells, and 8 ml of Qiagen (Valencia, CA) RLT
buffer was added. The cells were scraped free from the
flask with a plastic cell scraper and the RNA was prepared
according to the Qiagen instructions or frozen at -80°C. A
DNase treatment step was included in the preparation
protocol according to the Qiagen instructions.
RNA amplification
RNA sample quality was assessed with an Agilent 2100
Bioanalyzer (Agilent Technologies, Inc. Santa Clara, CA).
Sample concentration was determined with the Nano-
drop ND-1000 Spectrophotometer (Nanodrop, Inc,
Wilmington, DE). RNA samples were amplified using the
Ambion MessageAmp kit [30]. Aminoallyl-UTP was
included in the RNA transcription step according to the
Ambion instructions. The amplified RNA (aRNA) was
labeled with Amersham CyDye Post-Labeling Reactive
Dye Packs (GE Healthcare Products, Piscataway, NJ) by
vacuum drying 4 µg of the aRNA, and resuspending it in
4.5 µl 0.2 M NaHCO3, and then adding 4.5 µl Cy3 or Cy5
dye. Dye was prepared by adding 22 µl DMSO to the con-
tents of a freshly-opened tube of dye. The aRNA was incu-
bated in the dark at room temperature for 2 hours, and the
reaction was terminated by the addition of 4.5 µl of 4 M
hydroxylamine. After incubation in the dark at room tem-
perature for 15 min, the reaction was diluted with 100 µl
of nuclease-free water, and then purified according to the
Qiagen (Valencia, CA) RNeasy Mini kit protocol. The
purified and labeled aRNA was assessed and quantified
with the Nanodrop ND-1000 Spectrophotometer.BMC Genomics 2007, 8:340 http://www.biomedcentral.com/1471-2164/8/340
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Hybridization of human genomic arrays
A total of 12 arrays were hybridized for each array type,
using an experimental design which emphasized direct
comparisons within a slide between the cytosolic fraction
and the nuclear and total fractions, randomizing assign-
ments with respect to day [see Additional file 2]. Samples
from the same cell fractions for the same day were labeled
with different dyes on different slides to control for dye
effects. The human genomic oligo microarrays, printed
with the Operon Human Genome Oligo Set V2.0, were
purchased from the Gladstone Institute of the University
of California San Francisco. The microarrays were rehy-
drated and snap-dried 3 times to expand the DNA spots.
After each rehydration step they were irradiated with 120
mJ uv in a Stratalinker (Stratagene, Inc., LaJolla, CA). The
arrays were washed for 10 min with agitation in 0.1%
SDS, then rinsed with nuclease-free water, and dried rap-
idly under a nitrogen stream. The hybridization mixture
consisted of 100 pMoles of Cy3 or Cy5 dye conjugated to
aRNA, in 100 µl of 2X SSC, 0.08% SDS, and 6% Liquid
Block (GE Healthcare Products, Piscataway, NJ), and was
applied under a glass 24 × 60 mm LifterSlip (Erie Scien-
tific, Portsmouth, NH) to the array surface. Hybridization
was performed at 55°C for 7 hr in a humidified chamber.
The arrays were washed successively for 5 min with 2X
SSC with 0.5% SDS at 55°C, 0.5X SSC at room tempera-
ture, and twice with 0.05X SSC. The arrays were rapidly
dried under a nitrogen stream, and scanned with a Gene-
pix 4200AL scanner (Molecular Devices, Sunnyvale, CA)
using 635 nm and 532 nm lasers. The Genepix 6.0 soft-
ware was used for quantitation of the scanned images.
Reverse-transcription of aRNA for miRNA microarrays
aRNA (3 µg) was incubated at 42°C for 2 hr with 1.5 µl
Powerscript (Clontech, Mountain View, CA), 25 µg/ml
random hexamers, 0.25 mM aminoallyl-dUTP, 0.625 mM
dCTP, 0.625 mM dATP, 0.625 mM dGTP, 0.375 mM
dTTP, and 30 units RNAsin (Promega Biosciences, Inc.,
Madison, WI) in the Powerscript buffer. The RNA was
hydrolyzed by incubation with 90 mM NaOH and 90 mM
EDTA at 65°C for 15 min. The pH of the cDNA was neu-
tralized with 1 M TRIS-HCl pH 7.0 (19 µl). The cDNA was
purified by addition of 26 µl 0.1 M NaAcetate, followed
by the Qiagen (Valencia, CA) Qiaquick protocol. The
cDNA was coupled to Cy3 or Cy5 dyes by using the proto-
col described above for aRNA. Cleanup of the cDNA was
by repetition of the Qiaquick protocol.
Hybridization of the miRNA microarrays
miRMax miRNA microarrays were purchased from the
W.M. Keck Center for Collaborative Neuroscience (The
State University of New Jersey, Rutgers, NJ). The slides
were washed and incubated with all of the cDNA from a
single reverse transcription reaction (1–1.5 µg total) as
described for the human genomic arrays above, except
that 24 × 30 mm LifterSlips with 80 µl volume was used,
and the hybridization temperature was 42°C. Scanning
and quantitation was as given above.
Data and Statistical Analyses
Similar protocols were used to analyze separately the data
from the human genomic and miRNA arrays. To account
for spot saturation and multiple spots with the same
intensity, quantile normalization was performed [63]
using cumulative percentages rather than overall ranks.
Following normalization, data from saturated spots were
deleted from the data set. Data manipulations and analy-
ses were completed in SAS 9.0 (SAS Institute, Cary, North
Carolina USA). For each gene, a mixed model ANOVA was
performed [64], modeling cell fraction and dye as fixed
effects, and slide, day, and spot nested within slide as ran-
dom effects. The FDR was computed using the qvalue rou-
tine [65,66] implemented in R [67]. Any effect in the
ANOVA model for a given gene with FDR < 0.05 was con-
sidered for further analysis. Significance of pair-wise con-
trasts among least-squares means following ANOVA was
determined for genes with FDR < 0.05. All p-values for
contrasts were used to compute the FDR. Contrasts with
FDRs < 0.05 were defined as significant for the purposes
of this study.
Data annotation
Annotation and further analysis were achieved with the
aid of the Clone/Gene ID converter [68] and Cluster and
Treeview [69] of the Gene Expression Pattern Analysis
Software Suite v3 [70], and the GO Toolbox [28]. Gene
ontology (GO) annotation and the analysis of over- and
under-representation of genes in different GO categories
was performed with GoToolbox [27]. Additionally the
software, Osprey v. 1.2 [48,49], was employed to examine
the relationships of proteins coded by the transcripts that
were enriched in the nucleus (with respect to the cyto-
plasm), and the cytoplasm (with respect to the nucleus).
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